Mount Sinai identifies first drug to demonstrate therapeutic effect in a type of autism
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS). Behavioral symptoms of PMS fall under the autism spectrum disorder category.
May 20, 2010